Literature DB >> 31688912

e-Cigarette Use Among Youth in the United States, 2019.

Karen A Cullen1, Andrea S Gentzke2, Michael D Sawdey1, Joanne T Chang1, Gabriella M Anic1, Teresa W Wang2, MeLisa R Creamer2, Ahmed Jamal2, Bridget K Ambrose1, Brian A King2.   

Abstract

Importance: The prevalence of e-cigarette use among US youth increased from 2011 to 2018. Continued monitoring of the prevalence of e-cigarette and other tobacco product use among youth is important to inform public health policy, planning, and regulatory efforts. Objective: To estimate the prevalence of e-cigarette use among US high school and middle school students in 2019 including frequency of use, brands used, and use of flavored products. Design, Setting, and Participants: Cross-sectional analyses of a school-based nationally representative sample of 19 018 US students in grades 6 to 12 participating in the 2019 National Youth Tobacco Survey. The survey was conducted from February 15, 2019, to May 24, 2019. Main Outcomes and Measures: Self-reported current (past 30-day) e-cigarette use estimates among high school and middle school students; frequent use (≥20 days in the past 30 days) and usual e-cigarette brand among current e-cigarette users; and use of flavored e-cigarettes and flavor types among current exclusive e-cigarette users (no use of other tobacco products) by school level and usual brand. Prevalence estimates were weighted to account for the complex sampling design.
Results: The survey included 10 097 high school students (mean [SD] age, 16.1 [3.0] years; 47.5% female) and 8837 middle school students (mean [SD] age, 12.7 [2.8] years; 48.7% female). The response rate was 66.3%. An estimated 27.5% (95% CI, 25.3%-29.7%) of high school students and 10.5% (95% CI, 9.4%-11.8%) of middle school students reported current e-cigarette use. Among current e-cigarette users, an estimated 34.2% (95% CI, 31.2%-37.3%) of high school students and 18.0% (95% CI, 15.2%-21.2%) of middle school students reported frequent use, and an estimated 63.6% (95% CI, 59.3%-67.8%) of high school students and 65.4% (95% CI, 60.6%-69.9%) of middle school students reported exclusive use of e-cigarettes. Among current e-cigarette users, an estimated 59.1% (95% CI, 54.8%-63.2%) of high school students and 54.1% (95% CI, 49.1%-59.0%) of middle school students reported JUUL as their usual e-cigarette brand in the past 30 days; among current e-cigarette users, 13.8% (95% CI, 12.0%-15.9%) of high school students and 16.8% (95% CI, 13.6%-20.7%) of middle school students reported not having a usual e-cigarette brand. Among current exclusive e-cigarette users, an estimated 72.2% (95% CI, 69.1%-75.1%) of high school students and 59.2% (95% CI, 54.8%-63.4%) of middle school students used flavored e-cigarettes, with fruit, menthol or mint, and candy, desserts, or other sweets being the most commonly reported flavors. Conclusions and Relevance: In 2019, the prevalence of self-reported e-cigarette use was high among high school and middle school students, with many current e-cigarette users reporting frequent use and most of the exclusive e-cigarette users reporting use of flavored e-cigarettes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31688912      PMCID: PMC6865299          DOI: 10.1001/jama.2019.18387

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  208 in total

Review 1.  Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies.

Authors:  Asti Jackson; Ben Grobman; Suchitra Krishnan-Sarin
Journal:  Neuropharmacology       Date:  2020-06-24       Impact factor: 5.250

2.  ENDS Device Type and Initiation of Combustible Tobacco Products Among Adolescents.

Authors:  Aslesha Sumbe; Stephanie L Clendennen; Samuel C Opara; Christian D Jackson; Baojiang Chen; Anna V Wilkinson; Melissa B Harrell
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

3.  Initiation of any tobacco and five tobacco products across 3 years among youth, young adults and adults in the USA: findings from the PATH Study Waves 1-3 (2013-2016).

Authors:  Cassandra A Stanton; Eva Sharma; Elizabeth L Seaman; Karin A Kasza; Kathryn C Edwards; Michael J Halenar; Kristie A Taylor; Hannah Day; Gabriella Anic; Lynn C Hull; Maansi Bansal-Travers; Jean Limpert; Lisa D Gardner; Hoda T Hammad; Nicolette Borek; Heather L Kimmel; Wilson M Compton; Andrew Hyland
Journal:  Tob Control       Date:  2020-05       Impact factor: 7.552

4.  E-cigarette devices used on school grounds.

Authors:  Asti Jackson; Grace Kong; Ran Wu; Meghan E Morean; Danielle R Davis; Deepa R Camenga; Dana A Cavallo; Krysten W Bold; Patricia Simon; Suchitra Krishnan-Sarin
Journal:  Addict Behav       Date:  2020-06-21       Impact factor: 3.913

Review 5.  Effects of nicotine on the translation of stem cell therapy.

Authors:  Alex Hp Chan; Ngan F Huang
Journal:  Regen Med       Date:  2020-07-03       Impact factor: 3.806

6.  The past is not the future in tobacco control.

Authors:  K Michael Cummings; Scott Ballin; David Sweanor
Journal:  Prev Med       Date:  2020-06-27       Impact factor: 4.018

7.  E-cigarette Marketing Regulations and Youth Vaping: Cross-Sectional Surveys, 2017-2019.

Authors:  David Hammond; Jessica L Reid; Robin Burkhalter; Vicki L Rynard
Journal:  Pediatrics       Date:  2020-07       Impact factor: 7.124

Review 8.  History repeats itself: Role of characterizing flavors on nicotine use and abuse.

Authors:  Theresa Patten; Mariella De Biasi
Journal:  Neuropharmacology       Date:  2020-06-01       Impact factor: 5.250

9.  Flavor and Nicotine Effects on E-cigarette Appeal in Young Adults: Moderation by Reason for Vaping.

Authors:  Adam M Leventhal; Tyler B Mason; Sam N Cwalina; Lauren Whitted; Marissa Anderson; Carly Callahan
Journal:  Am J Health Behav       Date:  2020-09-01

10.  Modeling smoking-attributable mortality among adults with major depression in the United States.

Authors:  Jamie Tam; Gemma M J Taylor; Kara Zivin; Kenneth E Warner; Rafael Meza
Journal:  Prev Med       Date:  2020-08-27       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.